Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
BIB-953 Usage and Synthesis Anticoagulant is another new oral anticoagulant drug approved by the U.S. Food and Drug Administration after warfarin to prevent stroke and embolism in patients with non-valvular atrial fibrillation , A non-peptide thrombin inhibitor, is a major advance in the field of anticoagulation therapy and the field of potentially fatal thrombosis prevention, and it is a milestone.
Product Categories : API Intermediates > Intermediate for CAS 872728-81-9
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.